Fuentes J, Bakare M, Munir K, Aguayo P, Gaddour N, Öner Ö, et al. Autism spectrum disorders. IACAPAP E-textb child Adolesc Ment Heal Geneva Int Assoc Child Adolesc Psychiatry Allied Prof. 2012;1–27.

Li X, Hu Z, He Y, Xiong Z, Long Z, Peng Y, et al. Association analysis of CNTNAP2 polymorphisms with autism in the Chinese Han population. Psychiatr Genet. 2010;20(3):113–7.

Kim YS, Leventhal BL, Koh Y-J, Fombonne E, Laska E, Lim E-C, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168(9):904–12.

Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020;9(Suppl1):S55.

S. Ozonoff, G. S. Young, A. Carter, D. Messinger, N. Yirmiya, and L. Zwaigenbaum, & Stone, WL (2011). Recurrence risk for autism spectrum disorders: A baby siblings research consortium study, Pediatrics, vol. 128, pp. e1–e8.

Abrahams BS, Tentler D, Perederiy J V, Oldham MC, Coppola G, Geschwind DH. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proc Natl Acad Sci. 2007;104(45):17849–54.

Nakabayashi K, Scherer SW. The human contactin-associated protein-like 2 gene (CNTNAP2) spans over 2 Mb of DNA at chromosome 7q35. Genomics. 2001;73(1):108–12.

Zare S, Mashayekhi F, Bidabadi E. The association of CNTNAP2 rs7794745 gene polymorphism and autism in Iranian population. J Clin Neurosci [Internet]. 2017;39:189–92. Available from: http://dx.doi.org/10.1016/j.jocn.2017.01.008.

Muftin NQ, Jubair S, Hadi SM. Identification of MTHFR genetic polymorphism in Iraqi autistic children. Gene Reports. 2020;18:100585.

Yassin AH, Al-Kazaz AKA, Muhsin HA. Identification of genetic mutations associated with autism in GABRB3 gene in Iraqi autistic patients. Iraqi J Sci. 2016;1184–91.

Jabbar ARAA, Jebor MA. Study of polymorphism in methionine synthase gene by RFLP-PCR in middle Euphrates region of Iraq. J Pharm Sci Res. 2018;10(12):3219.

Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol. 2009;19(2):231–4.

Peñagarikano O, Geschwind DH. What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med. 2012;18(3):156–63.

Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, Parod JM, et al. Recessive symptomatic focal epilepsy and mutant contactinassociated protein-like 2. N Engl J Med. 2006;354(13):1370–7.

Bakkaloglu B, O’Roak BJ, Louvi A, Gupta AR, Abelson JF, Morgan TM, et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet. 2008;82(1):165–73.

Jonsson L, Zettergren A, Pettersson E, Hovey D, Anckarsäter H, Westberg L, et al. Association study between autistic-like traits and polymorphisms in the autism candidate regions RELN, CNTNAP2, SHANK3, and CDH9/10. Mol Autism. 2014;5(1):1–9.

Poot M. A candidate gene association study further corroborates involvement of contactin genes in autism. Mol Syndromol. 2014;5(5): 229–35.

Sampath S, Bhat S, Gupta S, O’Connor A, West AB, Arking DE, et al. Defining the contribution of CNTNAP2 to autism susceptibility. PLoS One. 2013;8(10):e77906.

Nascimento PP, Bossolani-Martins AL, Rosan DBA, Mattos LC, Brandão-Mattos C, Fett-Conte AC. Single nucleotide polymorphisms in the CNTNAP2 gene in Brazilian patients with autistic spectrum disorder. Genet Mol Res. 2016;15(1):123.

Khalid M, Raza H, M. Driessen T, J. Lee P, Tejwani L, Sami A, et al. Genetic risk of autism spectrum disorder in a Pakistani population. Genes (Basel). 2020;11(10):1206.